0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Orthobiologics Market Insights, Forecast to 2029
Published Date: May 2023
|
Report Code: QYRE-Auto-0C8950
Home | Market Reports | Health| Pharmacy
Global Orthobiologics Market Insights and Forecast to 2028
BUY CHAPTERS

Global Orthobiologics Market Insights, Forecast to 2029

Code: QYRE-Auto-0C8950
Report
May 2023
Pages:126
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Orthobiologics Market Size

The global Orthobiologics market is projected to grow from US$ 5561.1 million in 2023 to US$ 7262.8 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.6% during the forecast period.

Orthobiologics Market

Orthobiologics Market

The US & Canada market for Orthobiologics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Orthobiologics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Orthobiologics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key manufacturers of Orthobiologics include Medtronic, NuVasive, Inc., Stryker Corporation, Zimmer Biomet Holdings, Orthofix International N.V., Anika Therapeutics, Inc., DePuy Synthes (Johnson & Johnson), Bioventus and Arthrex, Inc., etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes:

This report presents an overview of global market for Orthobiologics, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Orthobiologics, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Orthobiologics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Orthobiologics sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Orthobiologics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Orthobiologics sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Medtronic, NuVasive, Inc., Stryker Corporation, Zimmer Biomet Holdings, Orthofix International N.V., Anika Therapeutics, Inc., DePuy Synthes (Johnson & Johnson), Bioventus and Arthrex, Inc., etc.

Scope of Orthobiologics Market Report

Report Metric Details
Report Name Orthobiologics Market
Accounted market size in 2023 US$ 5561.1 million
Forecasted market size in 2029 US$ 7262.8 million
Base Year 2023
Forecasted years 2023 - 2029
Segment by Type
  • Bone Growth Stimulators (BGS)
  • Viscosupplements
  • Bone Graft Substitute
Segment by Application
  • Hospitals
  • Ambulatory Surgical Centres
  • Orthopaedics Clinics
Segment by Region
  • US & Canada
  • U.S.
  • Canada
  • China
  • Asia (excluding China)
  • Japan
  • South Korea
  • China Taiwan
  • Southeast Asia
  • India
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Middle East, Africa, Latin America
  • Brazil
  • Mexico
  • Turkey
  • Israel
  • GCC Countries
By Company Medtronic, NuVasive, Inc., Stryker Corporation, Zimmer Biomet Holdings, Orthofix International N.V., Anika Therapeutics, Inc., DePuy Synthes (Johnson & Johnson), Bioventus, Arthrex, Inc., SeaSpine Holdings Corporation, Sanofi-Aventis (Sanofi SA), Djo Global, Inc., Seikagaku Corporation, RTI Surgical, Inc., Heraeus Holding GmbH, Fidia Pharma USA Inc., TRB Chemedica International SA, Allosource, Musculoskeletal Transplant Foundation, Inc., Ito
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Orthobiologics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Orthobiologics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
  • Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
  • Chapter 8: China by type, by application sales and revenue for each segment.
  • Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Orthobiologics sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Orthobiologics Product Introduction
1.2 Market by Type
1.2.1 Global Orthobiologics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Bone Growth Stimulators (BGS)
1.2.3 Viscosupplements
1.2.4 Bone Graft Substitute
1.3 Market by Application
1.3.1 Global Orthobiologics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centres
1.3.4 Orthopaedics Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Orthobiologics Sales Estimates and Forecasts 2018-2029
2.2 Global Orthobiologics Revenue by Region
2.2.1 Global Orthobiologics Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Orthobiologics Revenue by Region (2018-2023)
2.2.3 Global Orthobiologics Revenue by Region (2024-2029)
2.2.4 Global Orthobiologics Revenue Market Share by Region (2018-2029)
2.3 Global Orthobiologics Sales Estimates and Forecasts 2018-2029
2.4 Global Orthobiologics Sales by Region
2.4.1 Global Orthobiologics Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Orthobiologics Sales by Region (2018-2023)
2.4.3 Global Orthobiologics Sales by Region (2024-2029)
2.4.4 Global Orthobiologics Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Orthobiologics Sales by Manufacturers
3.1.1 Global Orthobiologics Sales by Manufacturers (2018-2023)
3.1.2 Global Orthobiologics Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Orthobiologics in 2022
3.2 Global Orthobiologics Revenue by Manufacturers
3.2.1 Global Orthobiologics Revenue by Manufacturers (2018-2023)
3.2.2 Global Orthobiologics Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Orthobiologics Revenue in 2022
3.3 Global Key Players of Orthobiologics, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Orthobiologics Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Orthobiologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Orthobiologics, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Orthobiologics, Product Offered and Application
3.8 Global Key Manufacturers of Orthobiologics, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Orthobiologics Sales by Type
4.1.1 Global Orthobiologics Historical Sales by Type (2018-2023)
4.1.2 Global Orthobiologics Forecasted Sales by Type (2024-2029)
4.1.3 Global Orthobiologics Sales Market Share by Type (2018-2029)
4.2 Global Orthobiologics Revenue by Type
4.2.1 Global Orthobiologics Historical Revenue by Type (2018-2023)
4.2.2 Global Orthobiologics Forecasted Revenue by Type (2024-2029)
4.2.3 Global Orthobiologics Revenue Market Share by Type (2018-2029)
4.3 Global Orthobiologics Price by Type
4.3.1 Global Orthobiologics Price by Type (2018-2023)
4.3.2 Global Orthobiologics Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Orthobiologics Sales by Application
5.1.1 Global Orthobiologics Historical Sales by Application (2018-2023)
5.1.2 Global Orthobiologics Forecasted Sales by Application (2024-2029)
5.1.3 Global Orthobiologics Sales Market Share by Application (2018-2029)
5.2 Global Orthobiologics Revenue by Application
5.2.1 Global Orthobiologics Historical Revenue by Application (2018-2023)
5.2.2 Global Orthobiologics Forecasted Revenue by Application (2024-2029)
5.2.3 Global Orthobiologics Revenue Market Share by Application (2018-2029)
5.3 Global Orthobiologics Price by Application
5.3.1 Global Orthobiologics Price by Application (2018-2023)
5.3.2 Global Orthobiologics Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Orthobiologics Market Size by Type
6.1.1 US & Canada Orthobiologics Sales by Type (2018-2029)
6.1.2 US & Canada Orthobiologics Revenue by Type (2018-2029)
6.2 US & Canada Orthobiologics Market Size by Application
6.2.1 US & Canada Orthobiologics Sales by Application (2018-2029)
6.2.2 US & Canada Orthobiologics Revenue by Application (2018-2029)
6.3 US & Canada Orthobiologics Market Size by Country
6.3.1 US & Canada Orthobiologics Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Orthobiologics Sales by Country (2018-2029)
6.3.3 US & Canada Orthobiologics Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Orthobiologics Market Size by Type
7.1.1 Europe Orthobiologics Sales by Type (2018-2029)
7.1.2 Europe Orthobiologics Revenue by Type (2018-2029)
7.2 Europe Orthobiologics Market Size by Application
7.2.1 Europe Orthobiologics Sales by Application (2018-2029)
7.2.2 Europe Orthobiologics Revenue by Application (2018-2029)
7.3 Europe Orthobiologics Market Size by Country
7.3.1 Europe Orthobiologics Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Orthobiologics Sales by Country (2018-2029)
7.3.3 Europe Orthobiologics Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Orthobiologics Market Size
8.1.1 China Orthobiologics Sales (2018-2029)
8.1.2 China Orthobiologics Revenue (2018-2029)
8.2 China Orthobiologics Market Size by Application
8.2.1 China Orthobiologics Sales by Application (2018-2029)
8.2.2 China Orthobiologics Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Orthobiologics Market Size by Type
9.1.1 Asia Orthobiologics Sales by Type (2018-2029)
9.1.2 Asia Orthobiologics Revenue by Type (2018-2029)
9.2 Asia Orthobiologics Market Size by Application
9.2.1 Asia Orthobiologics Sales by Application (2018-2029)
9.2.2 Asia Orthobiologics Revenue by Application (2018-2029)
9.3 Asia Orthobiologics Sales by Region
9.3.1 Asia Orthobiologics Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Orthobiologics Revenue by Region (2018-2029)
9.3.3 Asia Orthobiologics Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Orthobiologics Market Size by Type
10.1.1 Middle East, Africa and Latin America Orthobiologics Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Orthobiologics Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Orthobiologics Market Size by Application
10.2.1 Middle East, Africa and Latin America Orthobiologics Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Orthobiologics Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Orthobiologics Sales by Country
10.3.1 Middle East, Africa and Latin America Orthobiologics Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Orthobiologics Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Orthobiologics Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Medtronic
11.1.1 Medtronic Company Information
11.1.2 Medtronic Overview
11.1.3 Medtronic Orthobiologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Medtronic Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Medtronic Recent Developments
11.2 NuVasive, Inc.
11.2.1 NuVasive, Inc. Company Information
11.2.2 NuVasive, Inc. Overview
11.2.3 NuVasive, Inc. Orthobiologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 NuVasive, Inc. Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 NuVasive, Inc. Recent Developments
11.3 Stryker Corporation
11.3.1 Stryker Corporation Company Information
11.3.2 Stryker Corporation Overview
11.3.3 Stryker Corporation Orthobiologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Stryker Corporation Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Stryker Corporation Recent Developments
11.4 Zimmer Biomet Holdings
11.4.1 Zimmer Biomet Holdings Company Information
11.4.2 Zimmer Biomet Holdings Overview
11.4.3 Zimmer Biomet Holdings Orthobiologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Zimmer Biomet Holdings Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Zimmer Biomet Holdings Recent Developments
11.5 Orthofix International N.V.
11.5.1 Orthofix International N.V. Company Information
11.5.2 Orthofix International N.V. Overview
11.5.3 Orthofix International N.V. Orthobiologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Orthofix International N.V. Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Orthofix International N.V. Recent Developments
11.6 Anika Therapeutics, Inc.
11.6.1 Anika Therapeutics, Inc. Company Information
11.6.2 Anika Therapeutics, Inc. Overview
11.6.3 Anika Therapeutics, Inc. Orthobiologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Anika Therapeutics, Inc. Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Anika Therapeutics, Inc. Recent Developments
11.7 DePuy Synthes (Johnson & Johnson)
11.7.1 DePuy Synthes (Johnson & Johnson) Company Information
11.7.2 DePuy Synthes (Johnson & Johnson) Overview
11.7.3 DePuy Synthes (Johnson & Johnson) Orthobiologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 DePuy Synthes (Johnson & Johnson) Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 DePuy Synthes (Johnson & Johnson) Recent Developments
11.8 Bioventus
11.8.1 Bioventus Company Information
11.8.2 Bioventus Overview
11.8.3 Bioventus Orthobiologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Bioventus Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bioventus Recent Developments
11.9 Arthrex, Inc.
11.9.1 Arthrex, Inc. Company Information
11.9.2 Arthrex, Inc. Overview
11.9.3 Arthrex, Inc. Orthobiologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Arthrex, Inc. Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Arthrex, Inc. Recent Developments
11.10 SeaSpine Holdings Corporation
11.10.1 SeaSpine Holdings Corporation Company Information
11.10.2 SeaSpine Holdings Corporation Overview
11.10.3 SeaSpine Holdings Corporation Orthobiologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 SeaSpine Holdings Corporation Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 SeaSpine Holdings Corporation Recent Developments
11.11 Sanofi-Aventis (Sanofi SA)
11.11.1 Sanofi-Aventis (Sanofi SA) Company Information
11.11.2 Sanofi-Aventis (Sanofi SA) Overview
11.11.3 Sanofi-Aventis (Sanofi SA) Orthobiologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Sanofi-Aventis (Sanofi SA) Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sanofi-Aventis (Sanofi SA) Recent Developments
11.12 Djo Global, Inc.
11.12.1 Djo Global, Inc. Company Information
11.12.2 Djo Global, Inc. Overview
11.12.3 Djo Global, Inc. Orthobiologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Djo Global, Inc. Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Djo Global, Inc. Recent Developments
11.13 Seikagaku Corporation
11.13.1 Seikagaku Corporation Company Information
11.13.2 Seikagaku Corporation Overview
11.13.3 Seikagaku Corporation Orthobiologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Seikagaku Corporation Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Seikagaku Corporation Recent Developments
11.14 RTI Surgical, Inc.
11.14.1 RTI Surgical, Inc. Company Information
11.14.2 RTI Surgical, Inc. Overview
11.14.3 RTI Surgical, Inc. Orthobiologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 RTI Surgical, Inc. Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 RTI Surgical, Inc. Recent Developments
11.15 Heraeus Holding GmbH
11.15.1 Heraeus Holding GmbH Company Information
11.15.2 Heraeus Holding GmbH Overview
11.15.3 Heraeus Holding GmbH Orthobiologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.15.4 Heraeus Holding GmbH Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Heraeus Holding GmbH Recent Developments
11.16 Fidia Pharma USA Inc.
11.16.1 Fidia Pharma USA Inc. Company Information
11.16.2 Fidia Pharma USA Inc. Overview
11.16.3 Fidia Pharma USA Inc. Orthobiologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.16.4 Fidia Pharma USA Inc. Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Fidia Pharma USA Inc. Recent Developments
11.17 TRB Chemedica International SA
11.17.1 TRB Chemedica International SA Company Information
11.17.2 TRB Chemedica International SA Overview
11.17.3 TRB Chemedica International SA Orthobiologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.17.4 TRB Chemedica International SA Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 TRB Chemedica International SA Recent Developments
11.18 Allosource
11.18.1 Allosource Company Information
11.18.2 Allosource Overview
11.18.3 Allosource Orthobiologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.18.4 Allosource Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Allosource Recent Developments
11.19 Musculoskeletal Transplant Foundation, Inc.
11.19.1 Musculoskeletal Transplant Foundation, Inc. Company Information
11.19.2 Musculoskeletal Transplant Foundation, Inc. Overview
11.19.3 Musculoskeletal Transplant Foundation, Inc. Orthobiologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.19.4 Musculoskeletal Transplant Foundation, Inc. Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Musculoskeletal Transplant Foundation, Inc. Recent Developments
11.20 Ito
11.20.1 Ito Company Information
11.20.2 Ito Overview
11.20.3 Ito Orthobiologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.20.4 Ito Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Ito Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Orthobiologics Industry Chain Analysis
12.2 Orthobiologics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Orthobiologics Production Mode & Process
12.4 Orthobiologics Sales and Marketing
12.4.1 Orthobiologics Sales Channels
12.4.2 Orthobiologics Distributors
12.5 Orthobiologics Customers
13 Market Dynamics
13.1 Orthobiologics Industry Trends
13.2 Orthobiologics Market Drivers
13.3 Orthobiologics Market Challenges
13.4 Orthobiologics Market Restraints
14 Key Findings in The Global Orthobiologics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Orthobiologics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Table 2. Major Manufacturers of Bone Growth Stimulators (BGS)
    Table 3. Major Manufacturers of Viscosupplements
    Table 4. Major Manufacturers of Bone Graft Substitute
    Table 5. Global Orthobiologics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Table 6. Global Orthobiologics Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. Global Orthobiologics Revenue by Region (2018-2023) & (US$ Million)
    Table 8. Global Orthobiologics Revenue by Region (2024-2029) & (US$ Million)
    Table 9. Global Orthobiologics Revenue Market Share by Region (2018-2023)
    Table 10. Global Orthobiologics Revenue Market Share by Region (2024-2029)
    Table 11. Global Orthobiologics Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 12. Global Orthobiologics Sales by Region (2018-2023) & (K Units)
    Table 13. Global Orthobiologics Sales by Region (2024-2029) & (K Units)
    Table 14. Global Orthobiologics Sales Market Share by Region (2018-2023)
    Table 15. Global Orthobiologics Sales Market Share by Region (2024-2029)
    Table 16. Global Orthobiologics Sales by Manufacturers (2018-2023) & (K Units)
    Table 17. Global Orthobiologics Sales Share by Manufacturers (2018-2023)
    Table 18. Global Orthobiologics Revenue by Manufacturers (2018-2023) & (US$ Million)
    Table 19. Global Orthobiologics Revenue Share by Manufacturers (2018-2023)
    Table 20. Global Key Players of Orthobiologics, Industry Ranking, 2021 VS 2022 VS 2023
    Table 21. Orthobiologics Price by Manufacturers 2018-2023 (USD/Unit)
    Table 22. Global Orthobiologics Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Orthobiologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orthobiologics as of 2022)
    Table 24. Global Key Manufacturers of Orthobiologics, Manufacturing Base Distribution and Headquarters
    Table 25. Global Key Manufacturers of Orthobiologics, Product Offered and Application
    Table 26. Global Key Manufacturers of Orthobiologics, Date of Enter into This Industry
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Orthobiologics Sales by Type (2018-2023) & (K Units)
    Table 29. Global Orthobiologics Sales by Type (2024-2029) & (K Units)
    Table 30. Global Orthobiologics Sales Share by Type (2018-2023)
    Table 31. Global Orthobiologics Sales Share by Type (2024-2029)
    Table 32. Global Orthobiologics Revenue by Type (2018-2023) & (US$ Million)
    Table 33. Global Orthobiologics Revenue by Type (2024-2029) & (US$ Million)
    Table 34. Global Orthobiologics Revenue Share by Type (2018-2023)
    Table 35. Global Orthobiologics Revenue Share by Type (2024-2029)
    Table 36. Orthobiologics Price by Type (2018-2023) & (USD/Unit)
    Table 37. Global Orthobiologics Price Forecast by Type (2024-2029) & (USD/Unit)
    Table 38. Global Orthobiologics Sales by Application (2018-2023) & (K Units)
    Table 39. Global Orthobiologics Sales by Application (2024-2029) & (K Units)
    Table 40. Global Orthobiologics Sales Share by Application (2018-2023)
    Table 41. Global Orthobiologics Sales Share by Application (2024-2029)
    Table 42. Global Orthobiologics Revenue by Application (2018-2023) & (US$ Million)
    Table 43. Global Orthobiologics Revenue by Application (2024-2029) & (US$ Million)
    Table 44. Global Orthobiologics Revenue Share by Application (2018-2023)
    Table 45. Global Orthobiologics Revenue Share by Application (2024-2029)
    Table 46. Orthobiologics Price by Application (2018-2023) & (USD/Unit)
    Table 47. Global Orthobiologics Price Forecast by Application (2024-2029) & (USD/Unit)
    Table 48. US & Canada Orthobiologics Sales by Type (2018-2023) & (K Units)
    Table 49. US & Canada Orthobiologics Sales by Type (2024-2029) & (K Units)
    Table 50. US & Canada Orthobiologics Revenue by Type (2018-2023) & (US$ Million)
    Table 51. US & Canada Orthobiologics Revenue by Type (2024-2029) & (US$ Million)
    Table 52. US & Canada Orthobiologics Sales by Application (2018-2023) & (K Units)
    Table 53. US & Canada Orthobiologics Sales by Application (2024-2029) & (K Units)
    Table 54. US & Canada Orthobiologics Revenue by Application (2018-2023) & (US$ Million)
    Table 55. US & Canada Orthobiologics Revenue by Application (2024-2029) & (US$ Million)
    Table 56. US & Canada Orthobiologics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 57. US & Canada Orthobiologics Revenue by Country (2018-2023) & (US$ Million)
    Table 58. US & Canada Orthobiologics Revenue by Country (2024-2029) & (US$ Million)
    Table 59. US & Canada Orthobiologics Sales by Country (2018-2023) & (K Units)
    Table 60. US & Canada Orthobiologics Sales by Country (2024-2029) & (K Units)
    Table 61. Europe Orthobiologics Sales by Type (2018-2023) & (K Units)
    Table 62. Europe Orthobiologics Sales by Type (2024-2029) & (K Units)
    Table 63. Europe Orthobiologics Revenue by Type (2018-2023) & (US$ Million)
    Table 64. Europe Orthobiologics Revenue by Type (2024-2029) & (US$ Million)
    Table 65. Europe Orthobiologics Sales by Application (2018-2023) & (K Units)
    Table 66. Europe Orthobiologics Sales by Application (2024-2029) & (K Units)
    Table 67. Europe Orthobiologics Revenue by Application (2018-2023) & (US$ Million)
    Table 68. Europe Orthobiologics Revenue by Application (2024-2029) & (US$ Million)
    Table 69. Europe Orthobiologics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 70. Europe Orthobiologics Revenue by Country (2018-2023) & (US$ Million)
    Table 71. Europe Orthobiologics Revenue by Country (2024-2029) & (US$ Million)
    Table 72. Europe Orthobiologics Sales by Country (2018-2023) & (K Units)
    Table 73. Europe Orthobiologics Sales by Country (2024-2029) & (K Units)
    Table 74. China Orthobiologics Sales by Type (2018-2023) & (K Units)
    Table 75. China Orthobiologics Sales by Type (2024-2029) & (K Units)
    Table 76. China Orthobiologics Revenue by Type (2018-2023) & (US$ Million)
    Table 77. China Orthobiologics Revenue by Type (2024-2029) & (US$ Million)
    Table 78. China Orthobiologics Sales by Application (2018-2023) & (K Units)
    Table 79. China Orthobiologics Sales by Application (2024-2029) & (K Units)
    Table 80. China Orthobiologics Revenue by Application (2018-2023) & (US$ Million)
    Table 81. China Orthobiologics Revenue by Application (2024-2029) & (US$ Million)
    Table 82. Asia Orthobiologics Sales by Type (2018-2023) & (K Units)
    Table 83. Asia Orthobiologics Sales by Type (2024-2029) & (K Units)
    Table 84. Asia Orthobiologics Revenue by Type (2018-2023) & (US$ Million)
    Table 85. Asia Orthobiologics Revenue by Type (2024-2029) & (US$ Million)
    Table 86. Asia Orthobiologics Sales by Application (2018-2023) & (K Units)
    Table 87. Asia Orthobiologics Sales by Application (2024-2029) & (K Units)
    Table 88. Asia Orthobiologics Revenue by Application (2018-2023) & (US$ Million)
    Table 89. Asia Orthobiologics Revenue by Application (2024-2029) & (US$ Million)
    Table 90. Asia Orthobiologics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 91. Asia Orthobiologics Revenue by Region (2018-2023) & (US$ Million)
    Table 92. Asia Orthobiologics Revenue by Region (2024-2029) & (US$ Million)
    Table 93. Asia Orthobiologics Sales by Region (2018-2023) & (K Units)
    Table 94. Asia Orthobiologics Sales by Region (2024-2029) & (K Units)
    Table 95. Middle East, Africa and Latin America Orthobiologics Sales by Type (2018-2023) & (K Units)
    Table 96. Middle East, Africa and Latin America Orthobiologics Sales by Type (2024-2029) & (K Units)
    Table 97. Middle East, Africa and Latin America Orthobiologics Revenue by Type (2018-2023) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Orthobiologics Revenue by Type (2024-2029) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Orthobiologics Sales by Application (2018-2023) & (K Units)
    Table 100. Middle East, Africa and Latin America Orthobiologics Sales by Application (2024-2029) & (K Units)
    Table 101. Middle East, Africa and Latin America Orthobiologics Revenue by Application (2018-2023) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Orthobiologics Revenue by Application (2024-2029) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Orthobiologics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 104. Middle East, Africa and Latin America Orthobiologics Revenue by Country (2018-2023) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Orthobiologics Revenue by Country (2024-2029) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Orthobiologics Sales by Country (2018-2023) & (K Units)
    Table 107. Middle East, Africa and Latin America Orthobiologics Sales by Country (2024-2029) & (K Units)
    Table 108. Medtronic Company Information
    Table 109. Medtronic Description and Major Businesses
    Table 110. Medtronic Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 111. Medtronic Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Medtronic Recent Developments
    Table 113. NuVasive, Inc. Company Information
    Table 114. NuVasive, Inc. Description and Major Businesses
    Table 115. NuVasive, Inc. Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 116. NuVasive, Inc. Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. NuVasive, Inc. Recent Developments
    Table 118. Stryker Corporation Company Information
    Table 119. Stryker Corporation Description and Major Businesses
    Table 120. Stryker Corporation Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 121. Stryker Corporation Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Stryker Corporation Recent Developments
    Table 123. Zimmer Biomet Holdings Company Information
    Table 124. Zimmer Biomet Holdings Description and Major Businesses
    Table 125. Zimmer Biomet Holdings Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 126. Zimmer Biomet Holdings Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Zimmer Biomet Holdings Recent Developments
    Table 128. Orthofix International N.V. Company Information
    Table 129. Orthofix International N.V. Description and Major Businesses
    Table 130. Orthofix International N.V. Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 131. Orthofix International N.V. Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Orthofix International N.V. Recent Developments
    Table 133. Anika Therapeutics, Inc. Company Information
    Table 134. Anika Therapeutics, Inc. Description and Major Businesses
    Table 135. Anika Therapeutics, Inc. Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 136. Anika Therapeutics, Inc. Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Anika Therapeutics, Inc. Recent Developments
    Table 138. DePuy Synthes (Johnson & Johnson) Company Information
    Table 139. DePuy Synthes (Johnson & Johnson) Description and Major Businesses
    Table 140. DePuy Synthes (Johnson & Johnson) Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 141. DePuy Synthes (Johnson & Johnson) Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. DePuy Synthes (Johnson & Johnson) Recent Developments
    Table 143. Bioventus Company Information
    Table 144. Bioventus Description and Major Businesses
    Table 145. Bioventus Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 146. Bioventus Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Bioventus Recent Developments
    Table 148. Arthrex, Inc. Company Information
    Table 149. Arthrex, Inc. Description and Major Businesses
    Table 150. Arthrex, Inc. Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 151. Arthrex, Inc. Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Arthrex, Inc. Recent Developments
    Table 153. SeaSpine Holdings Corporation Company Information
    Table 154. SeaSpine Holdings Corporation Description and Major Businesses
    Table 155. SeaSpine Holdings Corporation Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 156. SeaSpine Holdings Corporation Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. SeaSpine Holdings Corporation Recent Developments
    Table 158. Sanofi-Aventis (Sanofi SA) Company Information
    Table 159. Sanofi-Aventis (Sanofi SA) Description and Major Businesses
    Table 160. Sanofi-Aventis (Sanofi SA) Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 161. Sanofi-Aventis (Sanofi SA) Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 162. Sanofi-Aventis (Sanofi SA) Recent Developments
    Table 163. Djo Global, Inc. Company Information
    Table 164. Djo Global, Inc. Description and Major Businesses
    Table 165. Djo Global, Inc. Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 166. Djo Global, Inc. Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 167. Djo Global, Inc. Recent Developments
    Table 168. Seikagaku Corporation Company Information
    Table 169. Seikagaku Corporation Description and Major Businesses
    Table 170. Seikagaku Corporation Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 171. Seikagaku Corporation Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 172. Seikagaku Corporation Recent Developments
    Table 173. RTI Surgical, Inc. Company Information
    Table 174. RTI Surgical, Inc. Description and Major Businesses
    Table 175. RTI Surgical, Inc. Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 176. RTI Surgical, Inc. Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 177. RTI Surgical, Inc. Recent Developments
    Table 178. Heraeus Holding GmbH Company Information
    Table 179. Heraeus Holding GmbH Description and Major Businesses
    Table 180. Heraeus Holding GmbH Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 181. Heraeus Holding GmbH Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 182. Heraeus Holding GmbH Recent Developments
    Table 183. Fidia Pharma USA Inc. Company Information
    Table 184. Fidia Pharma USA Inc. Description and Major Businesses
    Table 185. Fidia Pharma USA Inc. Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 186. Fidia Pharma USA Inc. Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 187. Fidia Pharma USA Inc. Recent Developments
    Table 188. TRB Chemedica International SA Company Information
    Table 189. TRB Chemedica International SA Description and Major Businesses
    Table 190. TRB Chemedica International SA Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 191. TRB Chemedica International SA Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 192. TRB Chemedica International SA Recent Developments
    Table 193. Allosource Company Information
    Table 194. Allosource Description and Major Businesses
    Table 195. Allosource Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 196. Allosource Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 197. Allosource Recent Developments
    Table 198. Musculoskeletal Transplant Foundation, Inc. Company Information
    Table 199. Musculoskeletal Transplant Foundation, Inc. Description and Major Businesses
    Table 200. Musculoskeletal Transplant Foundation, Inc. Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 201. Musculoskeletal Transplant Foundation, Inc. Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 202. Musculoskeletal Transplant Foundation, Inc. Recent Developments
    Table 203. Ito Company Information
    Table 204. Ito Description and Major Businesses
    Table 205. Ito Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 206. Ito Orthobiologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 207. Ito Recent Developments
    Table 208. Key Raw Materials Lists
    Table 209. Raw Materials Key Suppliers Lists
    Table 210. Orthobiologics Distributors List
    Table 211. Orthobiologics Customers List
    Table 212. Orthobiologics Market Trends
    Table 213. Orthobiologics Market Drivers
    Table 214. Orthobiologics Market Challenges
    Table 215. Orthobiologics Market Restraints
    Table 216. Research Programs/Design for This Report
    Table 217. Key Data Information from Secondary Sources
    Table 218. Key Data Information from Primary Sources
List of Figures
    Figure 1. Orthobiologics Product Picture
    Figure 2. Global Orthobiologics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Orthobiologics Market Share by Type in 2022 & 2029
    Figure 4. Bone Growth Stimulators (BGS) Product Picture
    Figure 5. Viscosupplements Product Picture
    Figure 6. Bone Graft Substitute Product Picture
    Figure 7. Global Orthobiologics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 8. Global Orthobiologics Market Share by Application in 2022 & 2029
    Figure 9. Hospitals
    Figure 10. Ambulatory Surgical Centres
    Figure 11. Orthopaedics Clinics
    Figure 12. Orthobiologics Report Years Considered
    Figure 13. Global Orthobiologics Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 14. Global Orthobiologics Revenue 2018-2029 (US$ Million)
    Figure 15. Global Orthobiologics Revenue Market Share by Region in Percentage: 2022 Versus 2029
    Figure 16. Global Orthobiologics Revenue Market Share by Region (2018-2029)
    Figure 17. Global Orthobiologics Sales 2018-2029 ((K Units)
    Figure 18. Global Orthobiologics Sales Market Share by Region (2018-2029)
    Figure 19. US & Canada Orthobiologics Sales YoY (2018-2029) & (K Units)
    Figure 20. US & Canada Orthobiologics Revenue YoY (2018-2029) & (US$ Million)
    Figure 21. Europe Orthobiologics Sales YoY (2018-2029) & (K Units)
    Figure 22. Europe Orthobiologics Revenue YoY (2018-2029) & (US$ Million)
    Figure 23. China Orthobiologics Sales YoY (2018-2029) & (K Units)
    Figure 24. China Orthobiologics Revenue YoY (2018-2029) & (US$ Million)
    Figure 25. Asia (excluding China) Orthobiologics Sales YoY (2018-2029) & (K Units)
    Figure 26. Asia (excluding China) Orthobiologics Revenue YoY (2018-2029) & (US$ Million)
    Figure 27. Middle East, Africa and Latin America Orthobiologics Sales YoY (2018-2029) & (K Units)
    Figure 28. Middle East, Africa and Latin America Orthobiologics Revenue YoY (2018-2029) & (US$ Million)
    Figure 29. The Orthobiologics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
    Figure 30. The Top 5 and 10 Largest Manufacturers of Orthobiologics in the World: Market Share by Orthobiologics Revenue in 2022
    Figure 31. Global Orthobiologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 32. Global Orthobiologics Sales Market Share by Type (2018-2029)
    Figure 33. Global Orthobiologics Revenue Market Share by Type (2018-2029)
    Figure 34. Global Orthobiologics Sales Market Share by Application (2018-2029)
    Figure 35. Global Orthobiologics Revenue Market Share by Application (2018-2029)
    Figure 36. US & Canada Orthobiologics Sales Market Share by Type (2018-2029)
    Figure 37. US & Canada Orthobiologics Revenue Market Share by Type (2018-2029)
    Figure 38. US & Canada Orthobiologics Sales Market Share by Application (2018-2029)
    Figure 39. US & Canada Orthobiologics Revenue Market Share by Application (2018-2029)
    Figure 40. US & Canada Orthobiologics Revenue Share by Country (2018-2029)
    Figure 41. US & Canada Orthobiologics Sales Share by Country (2018-2029)
    Figure 42. U.S. Orthobiologics Revenue (2018-2029) & (US$ Million)
    Figure 43. Canada Orthobiologics Revenue (2018-2029) & (US$ Million)
    Figure 44. Europe Orthobiologics Sales Market Share by Type (2018-2029)
    Figure 45. Europe Orthobiologics Revenue Market Share by Type (2018-2029)
    Figure 46. Europe Orthobiologics Sales Market Share by Application (2018-2029)
    Figure 47. Europe Orthobiologics Revenue Market Share by Application (2018-2029)
    Figure 48. Europe Orthobiologics Revenue Share by Country (2018-2029)
    Figure 49. Europe Orthobiologics Sales Share by Country (2018-2029)
    Figure 50. Germany Orthobiologics Revenue (2018-2029) & (US$ Million)
    Figure 51. France Orthobiologics Revenue (2018-2029) & (US$ Million)
    Figure 52. U.K. Orthobiologics Revenue (2018-2029) & (US$ Million)
    Figure 53. Italy Orthobiologics Revenue (2018-2029) & (US$ Million)
    Figure 54. Russia Orthobiologics Revenue (2018-2029) & (US$ Million)
    Figure 55. China Orthobiologics Sales Market Share by Type (2018-2029)
    Figure 56. China Orthobiologics Revenue Market Share by Type (2018-2029)
    Figure 57. China Orthobiologics Sales Market Share by Application (2018-2029)
    Figure 58. China Orthobiologics Revenue Market Share by Application (2018-2029)
    Figure 59. Asia Orthobiologics Sales Market Share by Type (2018-2029)
    Figure 60. Asia Orthobiologics Revenue Market Share by Type (2018-2029)
    Figure 61. Asia Orthobiologics Sales Market Share by Application (2018-2029)
    Figure 62. Asia Orthobiologics Revenue Market Share by Application (2018-2029)
    Figure 63. Asia Orthobiologics Revenue Share by Region (2018-2029)
    Figure 64. Asia Orthobiologics Sales Share by Region (2018-2029)
    Figure 65. Japan Orthobiologics Revenue (2018-2029) & (US$ Million)
    Figure 66. South Korea Orthobiologics Revenue (2018-2029) & (US$ Million)
    Figure 67. China Taiwan Orthobiologics Revenue (2018-2029) & (US$ Million)
    Figure 68. Southeast Asia Orthobiologics Revenue (2018-2029) & (US$ Million)
    Figure 69. India Orthobiologics Revenue (2018-2029) & (US$ Million)
    Figure 70. Middle East, Africa and Latin America Orthobiologics Sales Market Share by Type (2018-2029)
    Figure 71. Middle East, Africa and Latin America Orthobiologics Revenue Market Share by Type (2018-2029)
    Figure 72. Middle East, Africa and Latin America Orthobiologics Sales Market Share by Application (2018-2029)
    Figure 73. Middle East, Africa and Latin America Orthobiologics Revenue Market Share by Application (2018-2029)
    Figure 74. Middle East, Africa and Latin America Orthobiologics Revenue Share by Country (2018-2029)
    Figure 75. Middle East, Africa and Latin America Orthobiologics Sales Share by Country (2018-2029)
    Figure 76. Brazil Orthobiologics Revenue (2018-2029) & (US$ Million)
    Figure 77. Mexico Orthobiologics Revenue (2018-2029) & (US$ Million)
    Figure 78. Turkey Orthobiologics Revenue (2018-2029) & (US$ Million)
    Figure 79. Israel Orthobiologics Revenue (2018-2029) & (US$ Million)
    Figure 80. GCC Countries Orthobiologics Revenue (2018-2029) & (US$ Million)
    Figure 81. Orthobiologics Value Chain
    Figure 82. Orthobiologics Production Process
    Figure 83. Channels of Distribution
    Figure 84. Distributors Profiles
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Cell Signaling Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-32I5919
Mon May 20 00:00:00 UTC 2024

Add to Cart

Global Keytruda Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-4J8284
Sun May 19 00:00:00 UTC 2024

Add to Cart

Global Fc Fusion Protein for Eye Diseases Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-11F10758
Sun May 19 00:00:00 UTC 2024

Add to Cart

Global Nuclear Medicine Therapy Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-8W14462
Sun May 19 00:00:00 UTC 2024

Add to Cart